Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SARS-CoV-2-IN-1 is a potent inhibitor of Mpro(SARS-CoV-2 Mpro, SARS-CoV Mpro and MERS-CoV Mpro with IC50s of 0.67, 0.90 and 0.58 μM, respectively).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | 35 days | $ 730.00 |
Description | SARS-CoV-2-IN-1 is a potent inhibitor of Mpro(SARS-CoV-2 Mpro, SARS-CoV Mpro and MERS-CoV Mpro with IC50s of 0.67, 0.90 and 0.58 μM, respectively). |
In vitro | SARS-CoV-2-IN-1 inhibits RNA replication with an EC50 of 1.75 μM in a SARS-CoV replicon. In human Calu3 cells infected with the novel coronavirus, SARS-CoV-2, SARS-CoV-2-IN1(EC50 of 4-5 μM). |
In vivo | SARS-CoV-2-IN-1 demonstrates a maximum concentration (Cmax) of 126.2 ng/mL. It exhibits an extended mean residence time of 2.7 hours and a plasma half-life of 1.8 hours in CD-1 mice. |
Molecular Weight | 593.67 |
Formula | C31H39N5O7 |
CAS No. | 2412965-59-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SARS-CoV-2-IN-1 2412965-59-2 Others SARS CoV 2 IN 1 SARSCoV2IN1 inhibitor inhibit